Site içinde arama yapın

bir ses eklendi Health

2026-01-23 08:56:35 -

India Thalassemia Market: Is 2026 the Turning Point for a "Thalassemia-Free India by 2035"?

As of January 22, 2026, the India thalassemia market is identifying as a critical focus area within the nation’s healthcare agenda, with its 2026 valuation projected at approximately $193 million as part of a trajectory toward $294.5 million by 2035. The 2026 landscape is defined by a steady CAGR of 4.85%, driven by a massive government-led push for preventive screening and the rising...

0 Yorumlar 0 hisse senetleri 555 Views 0 önizleme